Works matching Multiple sclerosis treatment

Results: 5000

Treatment of Secondary Progressive Multiple Sclerosis: Current Recommendations and Future Prospects.

Published in:

BioDrugs, 1999, v. 12, n. 4, p. 267, doi. 10.2165/00063030-199912040-00004

By:

Rice, G.P.A.

Publication type:

Article

Early-Stage Multiple Sclerosis: What Are the Treatment Options?

Published in:

Drugs, 2004, v. 64, n. 18, p. 2021, doi. 10.2165/00003495-200464180-00002

By:

Sorensen, Per Soelberg

Publication type:

Article

Agresyvios eigos recidyvuojančios remituojančios išsėtinės sklerozės gydymas natalizumabu.

Published in:

Neurologijos Seminarai, 2012, v. 16, n. 4, p. 289

By:

Aleknaitė, L.;
Kizlaitienė, R.;
Kaubrys, G.;
Budrys, V.

Publication type:

Article

Treatment of Multiple Sclerosis with the Interferon-βs: Comparative Risks and Benefits.

Published in:

BioDrugs, 1998, v. 10, n. 6, p. 463, doi. 10.2165/00063030-199810060-00004

By:

Herndon, R.M.

Publication type:

Article

Localized Panniculitis and Subsequent Lipoatrophy with Subcutaneous Glatiramer Acetate (Copaxone<sup>®</sup>) Injection for the Treatment of Multiple Sclerosis.

Published in:

American Journal of Clinical Dermatology, 2004, v. 5, n. 5, p. 357, doi. 10.2165/00128071-200405050-00009

By:

Soós, Noemi;
Shakery, Kaweh;
Mrowietz, Ulrich

Publication type:

Article

Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?

Published in:

CNS Drugs, 1999, v. 11, n. 2, p. 133, doi. 10.2165/00023210-199911020-00005

By:

Weilbach, F.X.;
Gold, R.

Publication type:

Article

What is New in the Treatment of Multiple Sclerosis?

Published in:

Drugs, 2000, v. 59, n. 3, p. 401, doi. 10.2165/00003495-200059030-00002

By:

Weinstock-Guttman, B.;
Jacobs, L.D.

Publication type:

Article

Long-term treatment of multiple sclerosis with interferon-beta may be cost effective.

Published in:

2000

By:

Kendrick, M.;
Johnson, K.I.

Publication type:

journal article

Combination therapy for multiple sclerosis: the treatment strategy of the future?

Published in:

2004

By:

Weinstock-Guttman, Bianca;
Bakshi, Rohit

Publication type:

journal article

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Published in:

2018

By:

Riordan, Neil H.;
Morales, Isabela;
Fernández, Giselle;
Allen, Nicole;
Fearnot, Neal E.;
Leckrone, Michael E.;
Markovich, Dedra Jones;
Mansfield, Darla;
Avila, Dorita;
Patel, Amit N.;
Kesari, Santosh;
Paz Rodriguez, Jorge;
Fernández, Giselle

Publication type:

journal article

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.

Published in:

Patient Preference & Adherence, 2014, v. 8, p. 1123, doi. 10.2147/PPA.S68698

By:

Caporro, Matteo;
Disanto, Giulio;
Gobbi, Claudio;
Zecca, Chiara

Publication type:

Article

A REVIEW ON ADVANCEMENTS IN MULTIPLE SCLEROSIS AND ITS TREATMENT.

Published in:

Journal of Advanced Scientific Research, 2020, v. 11, n. 2, p. 10

By:

Bhuvaneswari, Mylipilli;
Prabhakar, Orsu;
Arun, Koyyada

Publication type:

Article

The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.

Published in:

Journal of Neurology, 2018, v. 265, n. 3, p. 701, doi. 10.1007/s00415-018-8764-4

By:

Landfeldt, Erik;
Castelo-Branco, Anna;
Svedbom, Axel;
Löfroth, Emil;
Kavaliunas, Andrius;
Hillert, Jan

Publication type:

Article

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 4, p. 503, doi. 10.1177/1352458509359727

By:

Freedman, Mark S.;
Bar-Or, Amit;
Atkins, Harold L.;
Karussis, Dimitrios;
Frassoni, Francesco;
Lazarus, Hillard;
Scolding, Neil;
Slavin, Shimon;
Le Blanc, Katarina;
Uccelli, Antonio

Publication type:

Article

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 10, p. 1175, doi. 10.1177/1352458509107007

By:

Goodin, D. S.;
Bates, D.

Publication type:

Article

European and American Guidelines for Multiple Sclerosis Treatment.

Published in:

Neurology & Therapy, 2018, v. 7, n. 2, p. 189, doi. 10.1007/s40120-018-0112-1

By:

Ghezzi, Angelo

Publication type:

Article

Clinical Roundup: Selected Treatment Options for Multiple Sclerosis—Part 2.

Published in:: Alternative & Complementary Therapies, 2019, v. 25, n. 5, p. 269, doi. 10.1089/act.2019.29236.cru
Publication type:: Article

Multiple sclerosis: effect of beta interferon treatment on survival.

Published in:

2019

By:

Kingwell, Elaine;
Leray, Emmanuelle;
Zhu, Feng;
Petkau, John;
Edan, Gilles;
Oger, Joel;
Tremlett, Helen

Publication type:

journal article

The IMCO Scheme as a Tool in Developing Team-Based Treatment for People with Multiple Sclerosis.

Published in:

Journal of Alternative & Complementary Medicine, 2008, v. 14, n. 1, p. 69, doi. 10.1089/acm.2007.0593

By:

Launsø, Laila;
Skovgaard, Lasse

Publication type:

Article

Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report.

Published in:

Journal of Central Nervous System Disease, 2020, p. 1, doi. 10.1177/1179573520973820

By:

Iovino, Aniello;
Aruta, Francesco;
Dubbioso, Raffaele;
Ruggiero, Lucia;
Tozza, Stefano;
Spina, Emanuele;
Manganelli, Fiore;
Iodice, Rosa

Publication type:

Article

Current issues in immunomodulatory treatment of multiple sclerosis: A practical approach.

Published in:

Journal of Neurology, 2006, v. 253, p. I32, doi. 10.1007/s00415-006-1108-9

By:

Stangel, Martin;
Gold, Ralf;
Gass, Achim;
Haas, Judith;
Jung, Stefan;
Elias, Wolfgang;
Uwe K. Zettl

Publication type:

Article

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis.

Published in:

2017

By:

Guarnera, Cristina;
Bramanti, Placido;
Mazzon, Emanuela

Publication type:

journal article

Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis.

Published in:

Current Journal of Neurology, 2021, v. 20, n. 3, p. 154

By:

Ayati, Nayyereh;
Taheri, Saeed;
Sahraian, Mohammad Ali;
Nikfar, Shekoufeh

Publication type:

Article

Multiple sclerosis and pregnancy - treatment considerations.

Published in:

Journal of Pre-Clinical & Clinical Research, 2020, v. 14, n. 4, p. 126, doi. 10.26444/jpccr/127671

By:

Kamieniak, Maciej Piotr;
Wolanin, Natalia;
Jarosz, Piotr;
Kobiałka, Izabela;
Kośmider, Kamil;
Petit, Véronique;
Rejdak, Konrad

Publication type:

Article

Course of therapy in patients with active relapsing-remitting multiple sclerosis despite first-line treatment.

Published in:

Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2023, v. 32, n. 2, p. 59, doi. 10.5114/ppn.2023.129048

By:

Bartosik-Psujek, Halina;
Adamczyk-Sowa, Monika;
Kułakowska, Alina;
Głażewska, Joanna;
Smaga, Anna;
Brola, Waldemar

Publication type:

Article

Bruton's tyrosine kinase inhibitors in the treatment of multiple sclerosis.

Published in:

Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2023, v. 32, n. 1, p. 23, doi. 10.5114/ppn.2023.126319

By:

Shulga, Olga;
Chabanova, Anna;
Kotsiuba, Oleksandra

Publication type:

Article

Multiple Sclerosis: Immunopathology and Treatment Update.

Published in:

Brain Sciences (2076-3425), 2017, v. 7, n. 7, p. 78, doi. 10.3390/brainsci7070078

By:

Dargahi, Narges;
Katsara, Maria;
Tselios, Theodore;
Androutsou, Maria-Eleni;
de Courten, Maximilian;
Matsoukas, John;
Apostolopoulos, Vasso

Publication type:

Article

Monoclonal antibodies in treatment of multiple sclerosis.

Published in:

Clinical & Experimental Immunology, 2014, v. 175, n. 3, p. 373, doi. 10.1111/cei.12197

By:

Rommer, P. S.;
Dudesek, A.;
Stüve, O.;
Zettl, U.K.

Publication type:

Article

Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis.

Published in:

Current Medical Research & Opinion, 2008, v. 24, n. 9, p. 2679, doi. 10.1185/03007990802329959

By:

Harold Moses;
David W. Brandes

Publication type:

Article

The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.

Published in:

2015

By:

Naderi, Nima

Publication type:

Editorial

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain.

Published in:

Patient Preference & Adherence, 2019, v. 13, p. 261, doi. 10.2147/PPA.S187983

By:

Verdugo, Ramón Morillo;
Herráiz, Esther Ramírez;
Olmo, Raquel Fernández-Del;
Bonet, Montserrat Roig;
García, María Valdivia

Publication type:

Article

An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug.

Published in:

Patient Preference & Adherence, 2017, v. 11, p. 55, doi. 10.2147/PPA.S118107

By:

Munsell, Michael;
Frean, Molly;
Menzin, Joseph;
Phillips, Amy L.

Publication type:

Article

An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations.

Published in:

Patient Preference & Adherence, 2015, v. 9, p. 675, doi. 10.2147/PPA.S20791

By:

Kornek, Barbara

Publication type:

Article

Enhanced patient support services improve patient persistence with multiple sclerosis treatment.

Published in:

Patient Preference & Adherence, 2014, v. 8, p. 805, doi. 10.2147/PPA.S59496

By:

Roche, Jane;
McCarry, Yvonne;
Mellors, Karen

Publication type:

Article

Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing–remitting multiple sclerosis.

Published in:

Acta Neurologica Scandinavica, 2006, v. 113, n. 5, p. 283, doi. 10.1111/j.1600-0404.2006.00585.x

By:

Etemadifar, M.;
Janghorbani, M.;
Shaygannejad, V.

Publication type:

Article

Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.

Published in:

Expert Review of Clinical Pharmacology, 2016, v. 9, n. 1, p. 49, doi. 10.1586/17512433.2016.1108189

By:

Constantinescu, Cris S;
Constantinescu, Simona E

Publication type:

Article

Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.

Published in:

Expert Review of Clinical Pharmacology, 2012, v. 5, n. 3, p. 245, doi. 10.1586/ECP.12.12

By:

Brück, Wolfgang;
Zamvil, Scott S.

Publication type:

Article

Monoclonal Antibodies for Multiple Sclerosis Treatment.

Published in:

Acta Médica Portuguesa, 2015, v. 28, n. 5, p. 640, doi. 10.20344/amp.6486

By:

PALAVRA, Filipe

Publication type:

Article

Multiple Sclerosis Treatment with Natalizumab: Analysis of a Hospital-Based Cohort.

Published in:

Acta Médica Portuguesa, 2014, v. 27, n. 4, p. 437, doi. 10.20344/amp.5032

By:

CARVALHO, Ana Teresa;
ABREU, Pedro;
JOSÉ SÁ, Maria

Publication type:

Article

Treatment Options for Relapsing-Remitting Multiple Sclerosis.

Published in:

Egyptian Journal of Hospital Medicine, 2017, v. 69, n. 3, p. 2093, doi. 10.12816/0041065

By:

Yara Mohsen Albalawi;
Sultan Sameer Alhunbusi;
Meshari Sultan Alsudayri;
Neda Ali Al-Bati;
Ahmad Hamza Omar Khalid;
Talal Hamid Alfallaj;
Elham Hamid Al Fallaj;
Abdulrahman Zaid Alshamrani;
Adilah Hamoud Al Turaifi;
Abdulrahman Mubarak Almutairi

Publication type:

Article

Prospects for the treatment of multiple sclerosis.

Published in:

1991

By:

Hughes, Richard A. C.

Publication type:

Editorial

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.

Published in:

International Journal of Molecular Sciences, 2015, v. 16, n. 7, p. 14951, doi. 10.3390/ijms160714951

By:

Kolb-Mäurer, Annette;
Goebeler, Matthias;
Mäurer, Mathias

Publication type:

Article

Multiple Sclerosis: From Molecules to Treatment.

Published in:

International Journal of Molecular Sciences, 2013, v. 14, n. 4, p. 7598, doi. 10.3390/ijms14047598

By:

Broadley, Simon A.

Publication type:

Article

Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?

Published in:

International Journal of Molecular Sciences, 2012, v. 13, n. 11, p. 14579, doi. 10.3390/ijms131114579

By:

Jalilian, Babak;
Einarsson, Halldór Bjarki;
Vorup-Jensen, Thomas

Publication type:

Article

A new era in the treatment of multiple sclerosis.

Published in:

Medical Journal of Australia, 2015, v. 203, n. 3, p. 139, doi. 10.5694/mja14.01218

By:

Broadley, Simon A.;
Barnett, Michael H.;
Boggild, Mike;
Brew, Bruce J.;
Butzkueven, Helmut;
Heard, Robert;
Hodgkinson, Suzanne;
Kermode, Allan G.;
Lechner-Scott, Jeannette;
Macdonell, Richard AL;
Marriott, Mark;
Mason, Deborah F.;
Parratt, John;
Reddel, Stephen W.;
Shaw, Cameron P.;
Slee, Mark;
Spies, Judith M.;
Taylor, Bruce V.;
Carroll, William M.;
Kilpatrick, Trevor J.

Publication type:

Article

Teriflunomid zur Behandlung der Multiplen Sklerose.

Published in:

Der Nervenarzt, 2013, v. 84, n. 6, p. 724, doi. 10.1007/s00115-013-3779-7

By:

Warnke, C.;
Meyer Zu Hörste, G.;
Menge, T.;
Stüve, O.;
Hartung, H.-P.;
Wiendl, H.;
Kieseier, B.C.

Publication type:

Article

Alemtuzumab als neue Therapieoption der Multiplen Sklerose.

Published in:

Der Nervenarzt, 2009, v. 80, n. 4, p. 468, doi. 10.1007/s00115-009-2681-9

By:

Warnke, C.;
Kieseier, B.C.;
Zettl, U.;
Hartung, H-P.

Publication type:

Article

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.

Published in:

Annals of Clinical & Translational Neurology, 2019, v. 6, n. 2, p. 252, doi. 10.1002/acn3.700

By:

Vollmer, Brandi L.;
Nair, Kavita V.;
Sillau, Stefan;
Corboy, John R.;
Vollmer, Timothy;
Alvarez, Enrique

Publication type:

Article

THE ROLE OF THE RECOVERY PROGRAM IN THE TREATMENT OF MULTIPLE SCLEROSIS.

Published in:

2017

By:

I. S., Neagoie;
D., Cinteză

Publication type:

Abstract

Disease-modifying treatments for multiple sclerosis - a review of approved medications.

Published in:

European Journal of Neurology, 2016, v. 23, p. 18, doi. 10.1111/ene.12883

By:

Torkildsen, Ø.;
Myhr, K.‐M.;
Bø, L.

Publication type:

Article